The state of Illinois currently has 13 active clinical trials seeking participants for Migraine research studies. These trials are conducted in various cities, including Chicago, Peoria, Springfield and Urbana.
A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine
Recruiting
This is a double-blind, randomized, multicenter, outpatient evaluation of the safety and efficacy of elismetrep as compared to placebo in the treatment of moderate or severe migraine.
Gender:
ALL
Ages:
Between 18 years and 70 years
Trial Updated:
04/22/2025
Locations: Cedar Crosse Research Center, Chicago, Illinois +1 locations
Conditions: Acute Migraine